Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
J Manag Care Spec Pharm
; 27(2): 256-262, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33506731
Full text:
1
Database:
MEDLINE
Main subject:
Pharmaceutical Services
/
4-Aminopyridine
/
Health Services Accessibility
/
Health Systems Plans
/
Multiple Sclerosis
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
America do norte
Language:
En
Journal:
J Manag Care Spec Pharm
Year:
2021
Type:
Article
Affiliation country:
Tunisia